Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence

The triple burden of COVID-19, tuberculosis and human immunodeficiency virus is one of the major global health challenges of the twenty-first century. In high burden HIV/TB countries, the spread of COVID-19 am...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Tags: Research article Source Type: research

Related Links:

In this study, we investigated a COVID-19 cohort in Shanghai, China. We screened viruses include Human parainfluenza virus 1, Human parainfluenza virus 2, Human parainfluenza virus 3, Human parainfluenza virus4, Influenza A virus, Influenza B virus, Human rhinovirus, Human metapneumovirus, Human respiratory syncytial virus, Human Bocavirus, Human adenovirus, Human Coronavirus 229E, Human Coronavirus NL63, Human Coronavirus HKU1, Human Coronavirus OC43; bacteria include Pseudomonas aeruginosa, Moraxella catarrhalis, Mycobacterium tuberculosis, Legionella pneumophila, Group A Streptococcus, Haemophilus influenza, Staphylococ...
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Letter to the Editor Source Type: research
[Govt of SA] North West Hospital converts its XDR Tb unit into COVID-19 ICU, due to a total drop of new cases recorded
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
Conclusions The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Tags: Respiratory infections and tuberculosis Reviews Source Type: research
The coronavirus disease 2019 (COVID-19) pandemic has inflicted a considerable pressure on populations, healthcare systems and community organisations worldwide, due to the fast spread of the disease and its huge global burden of morbidity and mortality, healthcare resource consumption, and societal and economic implications [1].
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Tags: Respiratory infections and tuberculosis Editorial Source Type: research
[Thomson Reuters Foundation] Johannesburg -- Zolelwa Sifumba described the daily injection she got to treat tuberculosis as feeling like hot lava being pumped slowly into her body, leaving the young South African doctor with crippling joint pain and incessant nausea.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
Abstract After South Korea raised its infectious disease alert to the highest level in response to coronavirus disease emergence, tuberculosis notification during the first 18 weeks of 2020 decreased significantly from the same period for each year during 2015-2019. Adequate measures to diagnose, control, and prevent tuberculosis need to be maintained. PMID: 32672531 [PubMed - indexed for MEDLINE]
Source: Emerging Infectious Diseases - Category: Infectious Diseases Authors: Tags: Emerg Infect Dis Source Type: research
Artificial intelligence (AI) is transforming healthcare delivery. The digital revolution in medicine and healthcare information is prompting a staggering growth of data intertwined with elements from many digital sources such as genomics, medical imaging and electronic health records. Such massive growth has sparked the development of an increasing number of AI-based applications that can be deployed in clinical practice. Pulmonary specialists who are familiar with the principles of AI and its applications will be empowered and prepared to seize future practice and research opportunities. The goal of this review is to prov...
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Tags: Lung biology and experimental studies, Respiratory infections and tuberculosis Reviews Source Type: research
Novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has rapidly spread throughout the world, resulting in a pandemic with high mortality. There are no effective treatments for the management of severe COVID-19 and current therapeutic trials are focused on antiviral therapy and attenuation of hyper-inflammation with anti-cytokine therapy. Severe COVID-19 pneumonia shares some pathological similarities with severe bacterial pneumonia and sepsis. In particular, it disrupts the haemostatic balance, which results in a procoagulant state locally in the lungs and syst...
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Tags: Respiratory infections and tuberculosis Reviews Source Type: research
Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions wit...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Task Force Report Source Type: research
We read with interest the letters by Tadolini et al. [1] and Stochino et al. [2] in a recent issue of the European Respiratory Journal, which summarise the first available evidence on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) [3].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Original Articles: Correspondence Source Type: research
More News: COVID-19 | Infectious Diseases | Tuberculosis